Kaiser Nurses Protest CEO’s AHA Appearance Over AI Concerns
As Kaiser Permanente CEO Greg Adams touted the success of his organization’s value-based care models at the AHA Leadership Summit in Denver, Kaiser nurses outside protested the health system's AI strategy. They claim they're being excluded from decisions about the technology.
GSK Eyes FDA Filing After Immunotherapy Succeeds in Key Rectal Cancer Study
GSK drug Jemperli met the main goal of a pivotal Phase 2 test in patients with a rare type of rectal cancer, paving the way for regulatory submissions. This antibody drug has already received a voucher to speed up its review under a new FDA pilot program.
Nearly 200 Organizations Back Bill to Expand Access to Clinical Trials
Nearly 200 healthcare and patient advocacy organizations endorsed the bipartisan Clinical Trial Modernization Act, which seeks to reduce financial barriers and expand access to clinical trials for underrepresented patients.
Healthcare Must Protect Innovation, Not Just Patient Data
Healthcare cybersecurity is no longer just about protecting electronic health records. It is increasingly about protecting the research, algorithms, clinical data, and intellectual property that drive the next generation of medicine.
Obesity Is Tied to Hundreds of Gene Variants — Why Are We Only Talking About Two?
Focusing on two gene variants obscures the more complex gene relationships that drive obesity. Here’s what we miss if we only focus on one gene variant at a time.